Zobrazeno 1 - 10
of 809
pro vyhledávání: '"Mauro Panteghini"'
Autor:
Anna Stefanska, Katarzyna Bergmann, Szymon Suwała, Aneta Mankowska-Cyl, Marek Kozinski, Roman Junik, Magdalena Krintus, Mauro Panteghini
Publikováno v:
Metabolites, Vol 14, Iss 1, p 52 (2024)
Metabolic dysfunction-associated fatty liver disease (MAFLD) may progress to advanced liver fibrosis (ALF). We evaluated the diagnostic accuracy of a novel Liver Fibrosis Risk Index (LFRI) in MAFLD subjects using transient elastography (TE) as the re
Externí odkaz:
https://doaj.org/article/eba41751a34b4ee1bb0b612b55079610
Autor:
Sarah Birindelli, Maciej S. Tarkowski, Marcello Gallucci, Marco Schiuma, Alice Covizzi, Przemysław Lewkowicz, Elena Aloisio, Felicia Stefania Falvella, Alberto Dolci, Agostino Riva, Massimo Galli, Mauro Panteghini
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/672cda4199d146d7a8cb55acb6aed4b6
Autor:
Sarah Birindelli, Maciej S. Tarkowski, Marcello Gallucci, Marco Schiuma, Alice Covizzi, Przemysław Lewkowicz, Elena Aloisio, Felicia Stefania Falvella, Alberto Dolci, Agostino Riva, Massimo Galli, Mauro Panteghini
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
A relevant portion of patients with disease caused by the severe acute respiratory syndrome coronavirus 2 (COVID-19) experience negative outcome, and several laboratory tests have been proposed to predict disease severity. Among others, dramatic chan
Externí odkaz:
https://doaj.org/article/b39a223c65164b09ad1ac0c295f59afa
Autor:
Magdalena Krintus, Mauro Panteghini
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 61:801-810
New millennium diagnostic criteria for acute myocardial infarction precipitated a revolutionary shift from an approach based primarily on electrocardiography and clinical symptoms to a strategy based on biomarkers, and preferably cardiac troponins (c
Publikováno v:
Clinical Chemistry. 69:228-238
Equivalent results for the same measurand in clinical samples (CSs), measured using different end-user in-vitro diagnostic medical devices (IVD-MDs), are essential for the application of clinical practice guidelines for diagnosis, treatment, monitori
Autor:
Mauro Panteghini
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 61:759-768
IVD manufacturers have total responsibility in terms of the traceability of marketed in vitro diagnostic medical devices (IVD-MD). This includes the provision of a quality control (QC) material as a part of the measuring system, suitable for traceabi
Autor:
Federica Braga, Sara Pasqualetti, Francesca Borrillo, Alessia Capoferri, Mariia Chibireva, Leila Rovegno, Mauro Panteghini
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 61:213-223
Laboratories should estimate and validate [using analytical performance specifications (APS)] the measurement uncertainty (MU) of performed tests. It is therefore essential to appropriately define APS for MU, but also to provide a perspective on suit
Publikováno v:
The Journal of Applied Laboratory Medicine. 8:420-422
Autor:
Tony, Badrick, Graham, Jones, W Greg, Miller, Mauro, Panteghini, Andrew, Quintenz, Sverre, Sandberg, Michael, Spannagl
Publikováno v:
Clinical Chemistry. 68:1238-1244
Autor:
Giulia Colombo, Dominika Szoke, Elena Aloisio, Francesco Cavigioli, Alberto Dolci, Mauro Panteghini
Publikováno v:
Clinical Chemistry. 68:887-891